Targeting TRPV1 and TRPA1: A feasible strategy for natural herbal medicines to combat postoperative ileus

Qi Liang1, Jing-Wen Wang1, Yu-Ru Bai1

  • 1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China.

Pharmacological Research
|September 14, 2023
PubMed

Insights

Natural compounds activating transient receptor potential vanilloid type 1 (TRPV1) and TRP ankyrin 1 (TRPA1) channels can enhance gastrointestinal motility and alleviate pain, offering a promising approach for managing postoperative ileus (POI).

Area of Science:

  • Gastroenterology and Pharmacology
  • Molecular and Cellular Biology
  • Natural Product Research

Background:

  • Postoperative ileus (POI) is a common complication after abdominal surgery, characterized by bowel dysfunction, pain, and inflammation.
  • Current pharmacological interventions for POI are limited, driving interest in alternative therapeutic strategies.
  • Transient receptor potential (TRP) channels, specifically TRPV1 and TRPA1, are expressed in the gastrointestinal tract and play roles in detecting stimuli and regulating functions.

Purpose of the Study:

  • To investigate the role of TRPV1 and TRPA1 channels in ameliorating postoperative ileus (POI).
  • To analyze the mechanisms by which natural compounds activate TRPV1 and TRPA1 to improve gastrointestinal motility and reduce pain.
  • To explore the potential of natural herbs as therapeutic agents for POI by targeting TRPV1/TRPA1 pathways.

Main Methods:

  • Review of existing literature on TRPV1 and TRPA1 channels in the gastrointestinal tract.
  • Analysis of studies detailing the activation of TRPV1/TRPA1 by natural compounds (e.g., capsaicin, allicin).
  • Examination of the downstream signaling pathways involved in neurotransmitter release and increased intestinal motility.

Main Results:

  • Activation of TRPV1 and TRPA1 channels by natural compounds stimulates neurotransmitter release, enhancing intestinal motility.
  • These activated channels provide protective effects against gastrointestinal injury.
  • Natural herbs are increasingly recognized for their potential to activate TRPV1/TRPA1 and manage POI symptoms.

Conclusions:

  • TRPV1 and TRPA1 channels are key targets for enhancing gastrointestinal function and pain relief in the context of POI.
  • Natural compounds offer a promising avenue for POI treatment by modulating TRPV1/TRPA1 activity.
  • Further research into natural herb-based therapies targeting TRPV1/TRPA1 could lead to effective treatments for POI.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
190
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
240
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
204
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
237
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
297
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
201